FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093910597> ?p ?o ?g. }

• W2093910597 endingPage "75" @default.
• W2093910597 startingPage "71" @default.
• W2093910597 abstract "Abstract. Purpose: To evaluate the effect of intravitreal bevacizumab on macular function in the cases of exudative age‐related macular degeneration (AMD). Methods: A total of 21 eyes of 21 patients with exudative AMD were included in this study. In each eye, at baseline and 1, 3 and 6 months after intravitreal bevacizumab injection, logMAR visual acuity, central 4° macular sensitivity, absolute scotoma size, fixation stability and fixation location by MP‐1 microperimetry and optical coherence tomography (OCT) foveal morphologic changes were assessed. After the initial treatment phase which included three consecutive injections, the decision to re‐treat was based on OCT and clinical findings. Subsequent injections could be administered at least 1 month after the previous injection period according to the OCT‐guided treatment regimen. Results: Mean retinal sensitivity within central 4° (12 points) area had increased from 3.69 ± 3.44 dB at baseline to 7.16 ± 3.27 dB at month 6. In all controls after the treatment, there was significant increase in logMAR visual acuity (p < 0.001) and MP‐1 retinal sensitivity (p < 0.001). Mean absolute scotoma in test point location had decreased significantly from 12 of the 76 applied test point locations measured at baseline to five test point locations (−7 test point locations; p < 0.001) at month 6 showing statistical significance. Fixation properties had preserved in all patients 6 months after intravitreal bevacizumab treatment. Conclusion: Intravitreal bevacizumab therapy induced a significant increase in mean retinal sensitivity and significant decrease in mean absolute scotoma size during 6 months. The MP1 microperimetry proved to be a valuable tool in the evaluation of functional benefit of exudative AMD therapy with intravitreal bevacizumab." @default.
• W2093910597 created "2016-06-24" @default.
• W2093910597 creator A5009231256 @default.
• W2093910597 creator A5057311332 @default.
• W2093910597 creator A5059531052 @default.
• W2093910597 creator A5071234111 @default.
• W2093910597 creator A5090823400 @default.
• W2093910597 date "2012-01-30" @default.
• W2093910597 modified "2023-10-18" @default.
• W2093910597 title "Microperimetric changes after intravitreal bevacizumab injection for exudative age-related macular degeneration" @default.
• W2093910597 cites W1539571840 @default.
• W2093910597 cites W2012279344 @default.
• W2093910597 cites W2021415488 @default.
• W2093910597 cites W2024093256 @default.
• W2093910597 cites W2029878969 @default.
• W2093910597 cites W2041759932 @default.
• W2093910597 cites W2056392188 @default.
• W2093910597 cites W2058775052 @default.
• W2093910597 cites W2065425407 @default.
• W2093910597 cites W2074304063 @default.
• W2093910597 cites W2075634939 @default.
• W2093910597 cites W2077985567 @default.
• W2093910597 cites W2086186570 @default.
• W2093910597 cites W2087780877 @default.
• W2093910597 cites W2088148914 @default.
• W2093910597 cites W2133402856 @default.
• W2093910597 cites W2157389251 @default.
• W2093910597 cites W2233259956 @default.
• W2093910597 cites W2328954905 @default.
• W2093910597 cites W2612675835 @default.
• W2093910597 doi "https://doi.org/10.1111/j.1755-3768.2009.01838.x" @default.
• W2093910597 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20163371" @default.
• W2093910597 hasPublicationYear "2012" @default.
• W2093910597 type Work @default.
• W2093910597 sameAs 2093910597 @default.
• W2093910597 citedByCount "26" @default.
• W2093910597 countsByYear W20939105972012 @default.
• W2093910597 countsByYear W20939105972013 @default.
• W2093910597 countsByYear W20939105972015 @default.
• W2093910597 countsByYear W20939105972016 @default.
• W2093910597 countsByYear W20939105972017 @default.
• W2093910597 countsByYear W20939105972018 @default.
• W2093910597 countsByYear W20939105972019 @default.
• W2093910597 countsByYear W20939105972021 @default.
• W2093910597 countsByYear W20939105972022 @default.
• W2093910597 countsByYear W20939105972023 @default.
• W2093910597 crossrefType "journal-article" @default.
• W2093910597 hasAuthorship W2093910597A5009231256 @default.
• W2093910597 hasAuthorship W2093910597A5057311332 @default.
• W2093910597 hasAuthorship W2093910597A5059531052 @default.
• W2093910597 hasAuthorship W2093910597A5071234111 @default.
• W2093910597 hasAuthorship W2093910597A5090823400 @default.
• W2093910597 hasBestOaLocation W20939105971 @default.
• W2093910597 hasConcept C118487528 @default.
• W2093910597 hasConcept C141071460 @default.
• W2093910597 hasConcept C146249460 @default.
• W2093910597 hasConcept C154945302 @default.
• W2093910597 hasConcept C2776403814 @default.
• W2093910597 hasConcept C2776694085 @default.
• W2093910597 hasConcept C2777802072 @default.
• W2093910597 hasConcept C2778257484 @default.
• W2093910597 hasConcept C2779100554 @default.
• W2093910597 hasConcept C2780827179 @default.
• W2093910597 hasConcept C2908647359 @default.
• W2093910597 hasConcept C2910004921 @default.
• W2093910597 hasConcept C41008148 @default.
• W2093910597 hasConcept C64731932 @default.
• W2093910597 hasConcept C71924100 @default.
• W2093910597 hasConcept C99454951 @default.
• W2093910597 hasConceptScore W2093910597C118487528 @default.
• W2093910597 hasConceptScore W2093910597C141071460 @default.
• W2093910597 hasConceptScore W2093910597C146249460 @default.
• W2093910597 hasConceptScore W2093910597C154945302 @default.
• W2093910597 hasConceptScore W2093910597C2776403814 @default.
• W2093910597 hasConceptScore W2093910597C2776694085 @default.
• W2093910597 hasConceptScore W2093910597C2777802072 @default.
• W2093910597 hasConceptScore W2093910597C2778257484 @default.
• W2093910597 hasConceptScore W2093910597C2779100554 @default.
• W2093910597 hasConceptScore W2093910597C2780827179 @default.
• W2093910597 hasConceptScore W2093910597C2908647359 @default.
• W2093910597 hasConceptScore W2093910597C2910004921 @default.
• W2093910597 hasConceptScore W2093910597C41008148 @default.
• W2093910597 hasConceptScore W2093910597C64731932 @default.
• W2093910597 hasConceptScore W2093910597C71924100 @default.
• W2093910597 hasConceptScore W2093910597C99454951 @default.
• W2093910597 hasIssue "1" @default.
• W2093910597 hasLocation W20939105971 @default.
• W2093910597 hasLocation W20939105972 @default.
• W2093910597 hasOpenAccess W2093910597 @default.
• W2093910597 hasPrimaryLocation W20939105971 @default.
• W2093910597 hasRelatedWork W1487328877 @default.
• W2093910597 hasRelatedWork W1964788367 @default.
• W2093910597 hasRelatedWork W2004692242 @default.
• W2093910597 hasRelatedWork W2035215834 @default.
• W2093910597 hasRelatedWork W2132724057 @default.
• W2093910597 hasRelatedWork W2147908385 @default.
• W2093910597 hasRelatedWork W2409763505 @default.
• W2093910597 hasRelatedWork W2891953983 @default.

• next